Delivery Order SPE2DB20D3303-SPE2DB24FA3AY
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D1041|SPE2DB24FUDG5, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a firm fixed price of $5,790.32 and an ultimate completion date of August 21, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,826,834 units of the prescription drug Candesartan Cilexetil 16 mg tablets. The firm-fixed-price delivery order contract has a ceiling value of $15,702.81 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which does not have a set-aside designation. This contract...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYJ3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,421,219 units of Candesartan Cilexetil 32 mg tablets in 90-count packages. The contract has a ceiling value of $16,747.80 and is a Firm Fixed Price Delivery Order contract, with a period of performance ending on November 14, 2024. The contract was awarded on November 13, 2024 and did not...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMCAH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of November 15, 2024, is for the delivery of Candesartan Cilexetil 16 mg tablets in 90-count packages. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,294.02. The contract does not have a...
This federal contract award, valued at $2,394.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,120,218 units of Candesartan Cilexetil 16 mg tablets, with a performance period through May 5, 2025. This award is not associated with a set-aside program and is a firm-fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor and has no...
This federal contract award, with ID SPE2DB24D2208|SPE2DB25FHHMV, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Candesartan Cilexetil 16 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,551.89 and a period of performance through April 17, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp, the prime contractor,...
This federal contract award, with identification number SPE2DB20D3505|SPE2DB25FU2R8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication, in quantities of 90 tablets per bottle. The contract has a ceiling value of $4,895.68 and an ultimate completion date of March 26, 2025. This award is part of a...
This federal contract award, valued at $4,264.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of December 20, 2024. This contract is not designated as a set-aside and is for open competition. AmerisourceBergen, as the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,243.97 firm-fixed-price delivery order is for the supply of 4,567,058,750 units of Candesartan Cilexetil 16 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of candesartan cilexetil 16 mg tablets. The contract has a firm fixed-price delivery order type and a ceiling value of $3,379.06, with a completion date of July 19, 2024. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous federal...